Prices are updated after-hours


Sort by: gain open | gain high | gain close | publishing date

symbols : PIRS    save search

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4–1BB/HER2 Bispecific Cinrebafusp Alfa
Published: 2022-01-14 (Crawled : 14:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: -3.76% H: 0.0% C: 0.0%

phase 2 als ces trial cancer
Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402
Published: 2022-01-03 (Crawled : 12:30) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 3.52% C: 1.82%

prs-060 phase 2 als ces trial
Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
FSTX | $4.16 | twitter stocktwits trandingview |
Health Technology
| | O: 2.87% H: 0.0% C: 0.0%
TTOO | $0.4006 | twitter stocktwits trandingview |
Health Technology
| | O: -1.2% H: 1.19% C: -1.35%
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.59% C: 0.77%


Pieris Pharmaceuticals and Servier Announce Dosing of First Patient in Phase 1/2 Trial of 4-1BB/PD-L1 Bispecific PRS-344/S095012
Published: 2021-11-08 (Crawled : 14:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.7% H: 1.86% C: -3.26%

phase 1 trial
Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 5.97% H: 0.56% C: -2.66%

financial results results
Pieris Pharmaceuticals To Host Third Quarter 2021 Investor Call and Provide Corporate Update on November 2, 2021
Published: 2021-10-26 (Crawled : 13:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.0% C: 0.0%


Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-10-19 (Crawled : 12:00) - biospace.com/
TTOO | $0.4006 | twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 3.92% C: 3.21%
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 1.37% H: 1.8% C: -0.68%
FSTX | $4.16 | twitter stocktwits trandingview |
Health Technology
| | O: 2.13% H: 9.47% C: 2.73%


Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer
Published: 2021-10-06 (Crawled : 13:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: -1.39% H: 2.21% C: -3.01%


BioSpace Movers & Shakers, Aug. 27
Published: 2021-08-27 (Crawled : 15:00) - biospace.com/
JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
VXRT | $5.05 | twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 1.78% C: 0.11%
ACAD | $21.87 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 4.2% C: 2.58%
IBIO | $0.45 | twitter stocktwits trandingview |
Health Technology
| | O: 1.64% H: 4.03% C: 2.42%
VNDA | $13.91 | twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 3.83% C: 3.35%
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 4.03% C: 2.68%
GH | $72.75 | twitter stocktwits trandingview |
Health Services
| | O: 0.43% H: 2.75% C: 1.7%
GNCA | $1.01 | twitter stocktwits trandingview |
Health Technology
| | O: 1.64% H: 0.0% C: -4.3%

space spac
Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor
Published: 2021-08-24 (Crawled : 15:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.0% C: -4.38%

presentation preclinical
Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
Published: 2021-08-23 (Crawled : 00:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 7.43% C: 6.93%
GH | $72.75 | twitter stocktwits trandingview |
Health Services
| | O: 1.19% H: 5.11% C: 4.88%

biopharma
Pieris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 3.59% C: 0.83%

financial results results
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.17% C: 0.17%
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 1.42% H: 2.38% C: 1.96%


Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis
Published: 2021-06-25 (Crawled : 12:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 12.13% H: 0.2% C: -18.37%

covid fibrosis
Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer
Published: 2021-06-24 (Crawled : 12:15) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 5.65% H: 22.19% C: 16.84%

treatment cancer drug
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
Published: 2021-05-25 (Crawled : 13:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 21.62% H: 68.44% C: 67.11%

collaboration respiratory
Pieris Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
Published: 2021-05-20 (Crawled : 13:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 3.17% C: 0.54%

conference
Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 1.6% H: 6.81% C: 0.52%

financial results results
Pieris Pharmaceuticals to Host First Quarter 2021 Investor Call and Provide Corporate Update on May 17, 2021
Published: 2021-05-10 (Crawled : 17:00) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 1.58% C: -4.74%


Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
Published: 2021-04-26 (Crawled : 13:15) - biospace.com/
PIRS | $3.34 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 6.8% C: 6.14%

license
Your saved searches


Save your searches and get alerts when important news are released.

Mentioned Today
COTY | News | $8.64 | twitter stocktwits trandingview |
Consumer Non-Durables

DXR | News | $11.16 | twitter stocktwits trandingview |
Health Technology

FCFS | News | $73.31 | twitter stocktwits trandingview |
Finance

INCY | News | $74.76 | twitter stocktwits trandingview |
Health Technology

KRP | News | $14.73 | twitter stocktwits trandingview |
Miscellaneous

LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology

OVLY | News | $17.6 | twitter stocktwits trandingview |
Finance